InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: Rubyred77 post# 124369

Friday, 10/13/2017 1:47:32 AM

Friday, October 13, 2017 1:47:32 AM

Post# of 470011
The other thing that cadno isn't assessing is the makeup of those enrolled in the trials. Were they mild or mild-mod alzheimers patients? What was the age range of those in the trial? I think the 273 trial enrolled older (or was it younger?) subjects and more further advanced with disease. Both factors make it harder to get improvement
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News